Home | About Us | Contact Us | Site Map | Locations
University of Washington Department of Urology Seal University of Washington | School of Medicine
Department of Urology
University of Washington | School of Medicine
Department of Urology

ALVIN Y. LIU, PhD

Research Associate Professor
Department of Urology
Institute for Stem Cell and Regenerative Medicine
School of Medicine University of Washington
Affiliated with the Institute for Systems Biology

Education & Training

Dr. Liu received his doctoral degree at the University of California, Los Angeles on the evolution of globin genes under Dr. Winston Salser.  He received a Damon Runyon-Walter Winchell Cancer Research fellowship to study antigenic variation in trypanosomes under Dr. Piet Borst at the University of Amsterdam and the Netherlands Cancer Institute.  Prior to his appointment at UW, he worked on human-mouse chimeric antibodies at INGENE, Santa Monica, and differential gene expression of prostate cancer at Cytometrics, San Diego.

Research Interests

Dr. Liu’s lab studies gene expression of urologic cancer cells (prostate, bladder and kidney), stem cell and differentiation, epithelial stromal cell-cell interaction, and cancer biomarkers.  The lab developed a procedure to isolate specific cell populations from organ tissue for downstream investigations such as transcriptome analysis and cell biology.

Public Database:
SCGAP Urologic Epithelial Stem Cells Project
The following link will appear in a new window.http://scgap.systemsbiology.net/

Research Funding

Biomarkers for Prostate and Bladder Cancer
NIH U01, PI: Alvin Liu. This project uses quantitative proteomics to identify secreted proteins that could be used as urinary biomarkers for cancer.  This research is a Biomarker Development Laboratory of the NCI EDRN group:
The following link will appear in a new window.http://edrn.nci.nih.gov/

Mechanisms and Markers of Prostate Cancer Metastases
NIH P01, PI: Paul H. Lange, Dr. Liu is co-director with Dr. Leroy Hood of the Institute for Systems Biology of project I.  The goals of this study are to determine the gene expression of the major normal prostate cell types and cancer cells, and to identify cancer specific genes.   

Urologic Epithelial Stem Cells – Prostate Morphogenesis and Cytodifferentiation
NIH U01, PI: Alvin Liu.  The goals are to characterize epithelial stem cells in the human prostate and bladder and the functional development of glandular epithelium under the influence of stromal mesenchyme cells and their secreted factors, and to determine the transcriptome of such stem cells isolated from prostate tissue specimens.

CD Expression in Prostate Cancer
NIH R21, PI: Alvin Liu.  The goals are to characterize prostate cancer cell types in primary tumors and metastases by expression of cell surface cluster designation (CD) antigens; and to develop an in vitro cell culture system to study prostate epithelial cell differentiation.

Use of ProteinChipTM to Discover Secreted Protein Markers for Prostate Cancer Diagnosis
CaP CURE Foundation, PI: Alvin Liu.  The goal of this study is to find protein markers for the diagnosis of prostate cancer.

Selected Publications

Oudes AJ, Campbell DS, Sorensen CM, Walashek LS, True LD, Liu AY.  Transcriptomes of human prostate cells.  BMC Genomics 7 (2006) 92.

Goo YA, Goodlett DR, Pascal LE, Worthington KD, Vessella RL, True LD, Liu AY.  Stromal mesenchyme cell genes of the human prostate and bladder.  BMC Urology 5 (2005) 17.

Oudes AJ, Roach JC, Walashek LS, Eichner LJ, True LD, Vessella RL, Liu AY.  Application of Affymetrix array and massively parallel signature sequencing for identification of genes involved in prostate cancer progression.  BMC Cancer 5 (2005) 86.

Liu AY, Zhang H, Sorensen CM, Diamond DL.  Analysis of prostate cancer by proteomics using tissue specimens.  J Urol 173 (2005) 73-8.

Liu AY, Roudier MP, True LD.  Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile.  Am J Pathol 165 (2004) 1543-56.

Liu AY, Brubaker KD, Goo YA, Quinn JE, Kral S, Sorensen CM, Vessella RL, Belldegrun AS, Hood LE.  Lineage relationship between LNCaP and LNCaP-derived prostate cancer cell lines.  Prostate 60 (2004) 98-108.

Freedland SJ, Seligson DB, Liu AY, Pantuck AJ, Paik SH, Horvath S, Wieder JA, Zisman A, Nguyen D, Tso C, Palotie AV, Belldegrun AS.  Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.  Prostate 55 (2003) 71-80.

Liu AY, True LD.  Characterization of prostate cell types by CD cell surface molecules.  Am J Pathol 160 (2002) 37-43.

Liu AY, Peehl DM.  Characterization of cultured human prostatic epithelial cells by cluster designation antigen expression.  Cell Tissue Res 305 (2001) 389-97.

Liu AY.  Differential expression of cell surface molecules in prostate cancer cells.  Cancer Res 60 (2000) 3429-3434.

Liu AY, LaTray L, van den Engh G.  Changes in cell surface molecules associated with in vitro culture of prostatic stromal cells.  Prostate 45 (2000) 303-12.

Liu AY, True LD, LaTray L, Ellis WJ, Vessella RL, Lange PH, Higano CS, Hood L, van den Engh G.  Analysis and sorting of prostate cancer cell types by flow cytometry.  Prostate 40 (1999) 192-9.

Liu AY, True LD, LaTray L, Nelson PS, Ellis WJ, Vessella RL, Lange PH, Hood L, van den Engh G.  Cell-cell interaction in prostate gene regulation and cytodifferentiation.  Proc Natl Acad Sci 94 (1997) 10705-10.

Liu AY, Corey E, Vessella RL, Lange PH, True LD, Huang GM, Nelson PS, Hood L.  Identification of differentially expressed genes: increased expression of transcription factor ETS-2 in prostate cancer.  Prostate 30 (1997) 145-53.

Liu AY, Corey E, Bladou F, Lange PH, Vessella RL.  Prostatic cell lineage markers: emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration.  Int J Cancer 65 (1996) 85-9.

Affiliations and Services

American Urological Association
American Association for the Advancement of Science

Dr. Liu served as ad hoc reviewer for the Canadian Prostate Cancer Research, UK Medical Research Council, the Atlantic Canada Opportunities Agency Atlantic Innovation Fund, and the Department of Defense.

Dr. Liu is a member of the editorial board of Asian Journal Andrology, and served as ad hoc reviewer for JAMA, Proteomics, Clin Chim Acta, BMC Cancer, Prostate, and J Urol.  

Curriculum Vitae [50K PDF*]

*Software capable of displaying a PDF is required for viewing or printing this document. You may download it from the Adobe website at http://www.adobe.com/products/acrobat/readstep2.html

 

[to top]

Contact Information:

ALVIN Y. LIU, PhD

Department of Urology
Box 356510
University of Washington
Seattle, WA 98195-6510
Ph: (206) 732-1268
Fax: (206) 732-1299